- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.39 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.2: 28 residues within 4Å:- Chain A: K.79, Q.81, R.123, R.188, P.190, A.223, G.224, G.225, G.226, Q.227, S.228, E.231, I.248, P.250, R.291, N.294, Y.295, S.296, H.328, V.329, A.362, T.363, G.364, Y.365, L.423
- Chain D: Y.289
- Ligands: FDA.1, BR.8
26 PLIP interactions:25 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:Q.227
- Hydrogen bonds: A:K.79, A:Q.81, A:R.188, A:G.225, A:S.228, A:S.228, A:E.231, A:R.291, A:N.294, A:N.294, A:S.296, A:S.296, A:S.296, A:V.329, A:V.329, D:Y.289
- Water bridges: A:G.226, A:G.226, A:Q.227, A:E.231, A:V.297, A:G.364, A:G.364, A:Y.365
- pi-Stacking: A:H.328
NAP.13: 26 residues within 4Å:- Chain B: K.79, Q.81, R.123, P.190, A.223, G.224, G.225, G.226, Q.227, S.228, E.231, I.248, P.250, R.291, N.294, Y.295, S.296, H.328, V.329, A.362, T.363, G.364, Y.365, L.423
- Chain C: Y.289
- Ligands: FDA.12
26 PLIP interactions:25 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:Q.227
- Hydrogen bonds: B:K.79, B:Q.81, B:G.225, B:Q.227, B:S.228, B:S.228, B:E.231, B:R.291, B:N.294, B:N.294, B:S.296, B:S.296, B:V.329, B:V.329, C:Y.289
- Water bridges: B:R.188, B:G.226, B:Q.227, B:S.228, B:A.229, B:S.296, B:V.297, B:G.364, B:Y.365
- pi-Cation interactions: B:H.328
NAP.22: 26 residues within 4Å:- Chain B: Y.289
- Chain C: K.79, Q.81, R.123, P.190, A.223, G.224, G.225, G.226, Q.227, S.228, E.231, I.248, P.250, R.291, N.294, Y.295, S.296, H.328, V.329, A.362, T.363, G.364, Y.365, L.423
- Ligands: FDA.21
25 PLIP interactions:25 interactions with chain C- Hydrophobic interactions: C:Q.227
- Hydrogen bonds: C:K.79, C:Q.81, C:R.188, C:G.225, C:S.228, C:S.228, C:E.231, C:R.291, C:N.294, C:N.294, C:S.296, C:S.296, C:V.329, C:V.329
- Water bridges: C:S.202, C:G.226, C:Q.227, C:Q.227, C:Q.227, C:A.229, C:R.291, C:S.296, C:G.364, C:Y.365
NAP.31: 26 residues within 4Å:- Chain A: Y.289
- Chain D: K.79, Q.81, R.123, P.190, A.223, G.224, G.225, G.226, Q.227, S.228, E.231, I.248, P.250, N.294, Y.295, S.296, H.328, V.329, A.362, T.363, G.364, Y.365, L.423
- Ligands: FDA.30, BR.40
28 PLIP interactions:27 interactions with chain D, 1 interactions with chain A- Hydrophobic interactions: D:Q.227
- Hydrogen bonds: D:K.79, D:Q.81, D:G.225, D:S.228, D:S.228, D:E.231, D:N.294, D:N.294, D:S.296, D:S.296, D:S.296, D:V.329, D:V.329, A:Y.289
- Water bridges: D:G.226, D:Q.227, D:Q.227, D:Q.227, D:A.229, D:R.291, D:R.291, D:N.294, D:A.362, D:G.364, D:Y.365, D:Y.365, D:Y.365
- 35 x BR: BROMIDE ION(Non-covalent)
BR.3: 4 residues within 4Å:- Chain A: R.92, T.429, G.432, E.433
Ligand excluded by PLIPBR.4: 4 residues within 4Å:- Chain A: R.393, Y.395, N.426, T.429
Ligand excluded by PLIPBR.5: 3 residues within 4Å:- Chain A: P.76, A.77, F.235
Ligand excluded by PLIPBR.6: 5 residues within 4Å:- Chain A: V.82, S.83, K.86, N.264
- Chain B: H.117
Ligand excluded by PLIPBR.7: 4 residues within 4Å:- Chain A: G.108, R.109, L.110, V.111
Ligand excluded by PLIPBR.8: 3 residues within 4Å:- Chain A: P.190, A.191
- Ligands: NAP.2
Ligand excluded by PLIPBR.9: 4 residues within 4Å:- Chain A: S.195, W.200, H.201, H.208
Ligand excluded by PLIPBR.10: 3 residues within 4Å:- Chain A: D.196, F.198, R.334
Ligand excluded by PLIPBR.11: 2 residues within 4Å:- Chain A: N.322, Y.352
Ligand excluded by PLIPBR.14: 4 residues within 4Å:- Chain B: G.108, R.109, L.110, V.111
Ligand excluded by PLIPBR.15: 5 residues within 4Å:- Chain A: H.117
- Chain B: V.82, S.83, K.86, N.264
Ligand excluded by PLIPBR.16: 4 residues within 4Å:- Chain B: L.75, P.76, A.77, F.235
Ligand excluded by PLIPBR.17: 3 residues within 4Å:- Chain B: R.92, T.429, G.432
Ligand excluded by PLIPBR.18: 5 residues within 4Å:- Chain B: S.195, W.200, H.201, R.204, H.208
Ligand excluded by PLIPBR.19: 2 residues within 4Å:- Chain B: D.274
- Chain C: L.326
Ligand excluded by PLIPBR.20: 5 residues within 4Å:- Chain B: R.393, Y.395, N.426, T.429, E.433
Ligand excluded by PLIPBR.23: 4 residues within 4Å:- Chain C: L.75, P.76, A.77, F.235
Ligand excluded by PLIPBR.24: 5 residues within 4Å:- Chain C: V.82, S.83, K.86, N.264
- Chain D: H.117
Ligand excluded by PLIPBR.25: 4 residues within 4Å:- Chain C: R.92, T.429, G.432, E.433
Ligand excluded by PLIPBR.26: 4 residues within 4Å:- Chain C: G.108, R.109, L.110, V.111
Ligand excluded by PLIPBR.27: 5 residues within 4Å:- Chain C: S.195, W.200, H.201, R.204, H.208
Ligand excluded by PLIPBR.28: 5 residues within 4Å:- Chain C: R.393, Y.395, N.426, T.429, E.433
Ligand excluded by PLIPBR.29: 2 residues within 4Å:- Chain C: E.314, P.319
Ligand excluded by PLIPBR.32: 3 residues within 4Å:- Chain A: D.274
- Chain D: L.326, A.347
Ligand excluded by PLIPBR.33: 3 residues within 4Å:- Chain A: L.326, A.347
- Chain D: D.274
Ligand excluded by PLIPBR.34: 4 residues within 4Å:- Chain D: G.108, R.109, L.110, V.111
Ligand excluded by PLIPBR.35: 5 residues within 4Å:- Chain C: H.117
- Chain D: V.82, S.83, K.86, N.264
Ligand excluded by PLIPBR.36: 4 residues within 4Å:- Chain D: L.75, P.76, A.77, F.235
Ligand excluded by PLIPBR.37: 3 residues within 4Å:- Chain D: R.92, T.429, G.432
Ligand excluded by PLIPBR.38: 4 residues within 4Å:- Chain D: S.195, W.200, H.201, H.208
Ligand excluded by PLIPBR.39: 2 residues within 4Å:- Chain D: Q.194, S.195
Ligand excluded by PLIPBR.40: 3 residues within 4Å:- Chain D: P.190, A.191
- Ligands: NAP.31
Ligand excluded by PLIPBR.41: 3 residues within 4Å:- Chain D: D.196, F.198, R.334
Ligand excluded by PLIPBR.42: 5 residues within 4Å:- Chain D: R.393, Y.395, N.426, T.429, E.433
Ligand excluded by PLIPBR.43: 1 residues within 4Å:- Chain D: A.336
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Setser, J.W. et al., Crystallographic Evidence of Drastic Conformational Changes in the Active Site of a Flavin-Dependent N-Hydroxylase. Biochemistry (2014)
- Release Date
- 2014-09-17
- Peptides
- KtzI: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.39 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 35 x BR: BROMIDE ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Setser, J.W. et al., Crystallographic Evidence of Drastic Conformational Changes in the Active Site of a Flavin-Dependent N-Hydroxylase. Biochemistry (2014)
- Release Date
- 2014-09-17
- Peptides
- KtzI: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D